Literature DB >> 15827324

RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro.

Peter J Wild1, Rene C Krieg, Juergen Seidl, Robert Stoehr, Kerstin Reher, Claudia Hofmann, Jari Louhelainen, André Rosenthal, Arndt Hartmann, Christian Pilarsky, Anja K Bosserhoff, Ruth Knuechel.   

Abstract

Photodynamic therapy using 5-aminolevulinic acid-induced protoporphyrin IX synthesis as a photosensitizing reagent is an encouraging modality for cancer treatment. Understanding the mechanism of tumor phototoxicity is important to provide a basis for combinatory therapy regimens. A normal cell line (UROtsa, urothelial) and two tumor cell lines (RT4, urothelial; HT29, colonic) were treated with cell line-specific LD50 doses of light after exposure to 5-aminolevulinic acid (100 microg/mL), and harvested for RNA extraction 0, 10, and 30 minutes after irradiation. The RNA was hybridized to the metg001A Affymetrix GeneChip containing 2,800 genes, focusing on cancer-related and growth regulatory targets. Comparing the gene expression profiles between the different samples, 40 genes (e.g., SOD2, LUC7A, CASP8, and DUSP1) were identified as significantly altered in comparison with the control samples, and grouped according to their gene ontology. We selected caspase-8 (CASP8) and dual specificity phosphatase 1 (DUSP1) for further validation of the array findings, and compared their expression with the expression of the immediate early gene FOS by quantitative reverse transcription-PCR. RNA expression of CASP8 stayed unchanged whereas DUSP1 RNA was up-regulated in normal and tumor cells starting 30 minutes after irradiation. In contrast, FOS RNA was found continuously up-regulated over time in all three cell lines. Induction of DUSP1 protein expression was clearly shown after 1 hour using Western blot analysis. Interestingly, no changes of caspase-8 protein expression but activation of catalytic activity was detected only in UROtsa cells starting 1 hour after photodynamic therapy, whereas no changes were seen in both tumor cell lines. According to caspase-8, the active caspase 3 fragment was found only in the normal urothelial cell line (UROtsa) 1 hour after photodynamic therapy. Combined data analysis suggests that photodynamic therapy in vitro (LD50) leads to apoptosis in UROtsa and to necrosis in the tumor cell lines, respectively. RNA expression profiling of normal and tumor cell lines following photodynamic therapy with 5-aminolevulinic acid gave insight into the major molecular mechanisms induced by photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827324     DOI: 10.1158/1535-7163.MCT-04-0141

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  13 in total

1.  [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].

Authors:  S Denzinger; A Hartmann; F Hofstaedter; R Knuechel; P J Wild; D Zaak; C Stief; W F Wieland; R Stoehr; M Burger
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

2.  Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer.

Authors:  Xiaohua Chen; Peng Zhao; Fengsheng Chen; Libo Li; Rongcheng Luo
Journal:  Lasers Med Sci       Date:  2010-07-30       Impact factor: 3.161

Review 3.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.

Authors:  José Bueno-Carrazco; Violeta Castro-Leyva; Fanny García-Gomez; Mario Solís-Paredes; Eva Ramon-Gallegos; Alfredo Cruz-Orea; Pilar Eguía-Aguilar; Francisco Arenas-Huertero
Journal:  Childs Nerv Syst       Date:  2012-06-19       Impact factor: 1.475

5.  5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells.

Authors:  Surajit Karmakar; Naren L Banik; Sunil J Patel; Swapan K Ray
Journal:  Neurosci Lett       Date:  2007-02-11       Impact factor: 3.046

6.  Apoptosis-associated genes related to photodynamic therapy in breast carcinomas.

Authors:  J C Silva; J Ferreira-Strixino; L C Fontana; L M Paula; L Raniero; A A Martin; R A Canevari
Journal:  Lasers Med Sci       Date:  2014-02-27       Impact factor: 3.161

7.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.

Authors:  D Nowis; M Legat; T Grzela; J Niderla; E Wilczek; G M Wilczynski; E Głodkowska; P Mrówka; T Issat; J Dulak; A Józkowicz; H Waś; M Adamek; A Wrzosek; S Nazarewski; M Makowski; T Stokłosa; M Jakóbisiak; J Gołab
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

8.  Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.

Authors:  Robert Kammerer; Alexander Buchner; Patrick Palluch; Thomas Pongratz; Konstantin Oboukhovskij; Wolfgang Beyer; Ann Johansson; Herbert Stepp; Reinhold Baumgartner; Wolfgang Zimmermann
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

9.  Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.

Authors:  M Gil; M Bieniasz; M Seshadri; D Fisher; M J Ciesielski; Y Chen; R K Pandey; D Kozbor
Journal:  Br J Cancer       Date:  2011-10-11       Impact factor: 7.640

10.  Synthesis of meso-substituted dihydro-1,3-oxazinoporphyrins.

Authors:  Satyasheel Sharma; Mahendra Nath
Journal:  Beilstein J Org Chem       Date:  2013-03-07       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.